463 related articles for article (PubMed ID: 17959252)
1. Comparison of biochemical effects of statins and fish oil in brain: the battle of the titans.
Farooqui AA; Ong WY; Horrocks LA; Chen P; Farooqui T
Brain Res Rev; 2007 Dec; 56(2):443-71. PubMed ID: 17959252
[TBL] [Abstract][Full Text] [Related]
2. Lipid mediators in the neural cell nucleus: their metabolism, signaling, and association with neurological disorders.
Farooqui AA
Neuroscientist; 2009 Aug; 15(4):392-407. PubMed ID: 19666894
[TBL] [Abstract][Full Text] [Related]
3. Lipid mediators and their metabolism in the nucleous: implications for Alzheimer's disease.
Farooqui AA
J Alzheimers Dis; 2012; 30 Suppl 2():S163-78. PubMed ID: 21955817
[TBL] [Abstract][Full Text] [Related]
4. Modulation of inflammation in brain: a matter of fat.
Farooqui AA; Horrocks LA; Farooqui T
J Neurochem; 2007 May; 101(3):577-99. PubMed ID: 17257165
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.
Pauwels EK; Kostkiewicz M
Drug News Perspect; 2008 Dec; 21(10):552-61. PubMed ID: 19221636
[TBL] [Abstract][Full Text] [Related]
6. Interactions between neural membrane glycerophospholipid and sphingolipid mediators: a recipe for neural cell survival or suicide.
Farooqui AA; Horrocks LA; Farooqui T
J Neurosci Res; 2007 Jul; 85(9):1834-50. PubMed ID: 17393491
[TBL] [Abstract][Full Text] [Related]
7. Fish oil feeding attenuates neuroinflammatory gene expression without concomitant changes in brain eicosanoids and docosanoids in a mouse model of Alzheimer's disease.
Hopperton KE; Trépanier MO; James NCE; Chouinard-Watkins R; Bazinet RP
Brain Behav Immun; 2018 Mar; 69():74-90. PubMed ID: 29109025
[TBL] [Abstract][Full Text] [Related]
8. Fish oil lipid emulsions and immune response: what clinicians need to know.
Waitzberg DL; Torrinhas RS
Nutr Clin Pract; 2009; 24(4):487-99. PubMed ID: 19605803
[TBL] [Abstract][Full Text] [Related]
9. Potential therapeutic role of statins in neurological disorders.
Bifulco M; Malfitano AM; Marasco G
Expert Rev Neurother; 2008 May; 8(5):827-37. PubMed ID: 18457539
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory effects of HMG-CoA reductase inhibitors.
Danesh FR; Anel RL; Zeng L; Lomasney J; Sahai A; Kanwar YS
Arch Immunol Ther Exp (Warsz); 2003; 51(3):139-48. PubMed ID: 12894868
[TBL] [Abstract][Full Text] [Related]
11. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases.
Calder PC
Mol Nutr Food Res; 2008 Aug; 52(8):885-97. PubMed ID: 18504706
[TBL] [Abstract][Full Text] [Related]
12. Essential fatty acids as possible mediators of the actions of statins.
Das UN
Prostaglandins Leukot Essent Fatty Acids; 2001 Jul; 65(1):37-40. PubMed ID: 11487306
[TBL] [Abstract][Full Text] [Related]
13. How do statins control neuroinflammation?
Adamson P; Greenwood J
Inflamm Res; 2003 Oct; 52(10):399-403. PubMed ID: 14520514
[TBL] [Abstract][Full Text] [Related]
14. Antioxidative effects of statins.
Adam O; Laufs U
Arch Toxicol; 2008 Dec; 82(12):885-92. PubMed ID: 18670762
[TBL] [Abstract][Full Text] [Related]
15. Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress.
Mason RP; Walter MF; Jacob RF
Circulation; 2004 Jun; 109(21 Suppl 1):II34-41. PubMed ID: 15173061
[TBL] [Abstract][Full Text] [Related]
16. [The pleiotropic effects of statins].
Wolfovitz E
Harefuah; 2005 Aug; 144(8):577-82, 597. PubMed ID: 16146158
[TBL] [Abstract][Full Text] [Related]
17. [Examples of results of pharmaceutical cerebrovascular protection, with special emphasis on the statins].
Bajnok L
Ideggyogy Sz; 2011 Mar; 64(5-6):151-6. PubMed ID: 21692273
[TBL] [Abstract][Full Text] [Related]
18. Statins--a cure-all for the brain?
Menge T; Hartung HP; Stüve O
Nat Rev Neurosci; 2005 Apr; 6(4):325-31. PubMed ID: 15803163
[TBL] [Abstract][Full Text] [Related]
19. Statins: mechanisms of neuroprotection.
van der Most PJ; Dolga AM; Nijholt IM; Luiten PG; Eisel UL
Prog Neurobiol; 2009 May; 88(1):64-75. PubMed ID: 19428962
[TBL] [Abstract][Full Text] [Related]
20. Impact of HMG-CoA reductase inhibition on brain pathology.
Zipp F; Waiczies S; Aktas O; Neuhaus O; Hemmer B; Schraven B; Nitsch R; Hartung HP
Trends Pharmacol Sci; 2007 Jul; 28(7):342-9. PubMed ID: 17573124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
